SARS-CoV2 Infection
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
9 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (8)
Total enrollment: 2,480 patients across 8 trials
Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine
Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 Vaccines
Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients
COVAXIN in a Pediatric Cohort
IMM-BCP-01 in Mild to Moderate COVID-19
Safety and Immunogenicity of HDT-301 Targeting a SARS-CoV-2 Variant Spike Protein
Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)
TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.